Starton Therapeutics Terminates Healthwell Acquisition Corp. I (HWEL) Deal
by Marlena Haddad on 2023-11-06 at 8:51am

Healthwell Acquisition Corp. I (Nasdaq: HWEL) announced on Friday evening that its former target Starton has terminated its business combination.

Although the parties did not provide extensive detail regarding the termination, they clarified that the deal fell through due to certain closing conditions not being satisfied by the outside date of November 3.

Healthwell I unveiled its $339 million combination with Starton earlier this year in April. While the two sides initially agreed on a $15 million closing condition, they later reduced this to $10 million in September.

The SPAC brought about $253.7 million into the deal through its trust, but following redemptions from previous votes, it was left with around $41.8 million. Despite the expectation of supplementing this with $15 million from a PIPE or a debt facility, there has been no confirmation of securing this funding.

Paramus, New Jersey-based Starton is developing a line of treatments to improve efficacies in delivering drugs for certain types of cancer and mitigating the side effects of chemotherapy. Going forward, Starton will continue its clinical efforts to meet the completion of its study for the advancement of its patients.

As a result of this termination, Healthwell I will seek an alternative business combination. With a completion deadline of December 5, it currently has just a month to find a suitable target to combine with. However, it recently filed a proxy to hold a shareholder meeting aimed at extending this deadline until August 2024, granting them a nine-month window to finalize a deal.

 

Recent Posts
by Nicholas Alan Clayton on 2024-05-28 at 7:50am

At the SPAC of Dawn Friday afternoons ahead of holiday weekends tend to be busy with filings and new SPAC registrations, but this Memorial Day passed with mostly minor adjustments to transactions and no new SPACs, after Perceptive Capital (NASDAQ:PCSC) and Centurion (NASDAQ:ALFUU) each filed for IPOs earlier last week. There is plenty of activity...

by Kristi Marvin on 2024-05-25 at 11:46am

Terms Tracker for the Week Ending May 24, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. It was a bonanza (relatively) of amended and new S-1 filings this week for SPACs. After the parched SPAC desert of April, May has been...

by Nicholas Alan Clayton on 2024-05-24 at 7:59am

At the SPAC of Dawn ‘Tis the season for secondary offerings, or so seems to be the case with recent de-SPACs. Three have announced offerings of shares and warrants over the past 24 hours, perhaps judging the market is more receptive now than in months past even if Thursday saw a late drop. Another potential...

by Nicholas Alan Clayton on 2024-05-23 at 3:58pm

Churchill VII (NYSE:CVII) has upped its enterprise value of target CorpAcq by +10.1% to $1.74 billion from $1.58 billion, according to a refreshed investor presentation released this morning. The new deck also provides some new numbers on CorpAcq’s estimated 2023 results and sheds some light on why Churchill VII may have postponed its May 21...

by Nicholas Alan Clayton on 2024-05-23 at 11:59am

Centurion Acquisition Corp. (NASDAQ:ALFUU) has filed for a $250 million IPO with a commitment by its sponsor group to try and get to its full allotment in-house. The S-1 includes language that “The sponsor limited partners have expressed to us an interest in purchase up to an aggregate of approximately $283,500,000 of the units in this...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved